APA (7th ed.) Citation

Ruane, P., Brinson, C., Ramgopal, M., Ryan, R., Coate, B., Cho, M., . . . Anderson, D. (2015). The Intelence aNd pRezista Once A Day Study (INROADS): A multicentre, single‐arm, open‐label study of etravirine and darunavir/ritonavir as dual therapy in HIV‐1‐infected early treatment‐experienced subjects. HIV medicine, 16(5), 288-296. https://doi.org/10.1111/hiv.12211

Chicago Style (17th ed.) Citation

Ruane, PJ, C. Brinson, M. Ramgopal, R. Ryan, B. Coate, M. Cho, TN Kakuda, and D. Anderson. "The Intelence ANd PRezista Once A Day Study (INROADS): A Multicentre, Single‐arm, Open‐label Study of Etravirine and Darunavir/ritonavir as Dual Therapy in HIV‐1‐infected Early Treatment‐experienced Subjects." HIV Medicine 16, no. 5 (2015): 288-296. https://doi.org/10.1111/hiv.12211.

MLA (9th ed.) Citation

Ruane, PJ, et al. "The Intelence ANd PRezista Once A Day Study (INROADS): A Multicentre, Single‐arm, Open‐label Study of Etravirine and Darunavir/ritonavir as Dual Therapy in HIV‐1‐infected Early Treatment‐experienced Subjects." HIV Medicine, vol. 16, no. 5, 2015, pp. 288-296, https://doi.org/10.1111/hiv.12211.